US Activist Hedge Fund Institutional SEC 13D 13G — October 13, 2026

13-10-2026

Dr. Simon G. Kukes, through The SGK 2018 Revocable Trust, filed Amendment No. 15 to Schedule 13D disclosing the October 8, 2026 purchase of 147,070 shares of PEDEVCO common stock at $13.00 per share (about $1.91 million) in a market transaction. The Reporting Persons report beneficial ownership of 4,137,543 shares for the Trust (31.1%) and 4,543,790 shares for Kukes including his spouse's 150 shares (34.2%), based on 13,292,013 shares outstanding as of September 15, 2026. The purchase was made for investment purposes, and the filing discloses no plans for board changes, mergers, or delisting.

• · Filing is Amendment No. 15 to the Schedule 13D, reflecting acquisitions by Kukes since Amendment No. 14
• · Ownership percentages are based on the 13,292,013 shares reported in the issuer's Form S-8 filed September 15, 2026
• · Shares were acquired under the October 2025 PIPE and shareholder/support agreements referenced in exhibits (Shareholder Agreement dated October 31, 2025)
• · Reporting Persons state no current plans for extraordinary transactions, board changes, delisting, or capitalization changes beyond those previously disclosed

13-10-2026

Empery Asset Management, LP and its managing principal Ryan M. Lane filed a Schedule 13G reporting beneficial ownership of 21,247,856 shares of Outlook Therapeutics, Inc. (OTLK) common stock, equal to 8.73% of the 243,447,554 shares outstanding as of August 14, 2026. The filing is made under Rule 13d-1(b) as a passive institutional holder, with the reporting persons certifying the shares were acquired in the ordinary course of business and not to influence control of the issuer.

• · Filing is a LIVE Schedule 13G reporting holdings as of September 30, 2026, under Rule 13d-1(b) (qualified institutional investor status).
• · Reporting persons disclaim beneficial ownership of shares held by other reporting persons except to the extent of pecuniary interest.
• · Empery Funds are managed by Empery Asset Management, LP; Ryan M. Lane is the managing member of the limited liability company that controls the general partner of the investment manager.
• · Subject company CIK 0001649989; SEC file number 005-89495; Outlook Therapeutics is a Delaware corporation headquartered in Iselin, NJ, classified under SIC 2836 (Biological Products).

13-10-2026

Tetragon Financial Group Limited, together with its investment manager Tetragon Financial Management LP and principals Patrick G. G. Dear and Reade E. Griffith, filed a Schedule 13G on October 13, 2026 reporting beneficial ownership of 9,708,153 ordinary shares of Silence Therapeutics plc, equal to 5.2% of the outstanding shares. The position is held as 3,236,051 ADSs and includes 1,500,000 shares (underlying 500,000 ADSs) issuable on exercise of call options. The filing is a passive-investor disclosure under Rule 13d-1(c), with the reporting persons certifying the shares were not acquired to influence control.

• · The reported event date is October 5, 2026, and the filing is a LIVE Schedule 13G under Rule 13d-1(c), which is a passive-investor filing.
• · The 5.2% stake is calculated on 186,461,401 shares outstanding, per the company's August 2026 prospectus and August 14, 2026 press release.
• · Each ADS represents three ordinary shares, with a nominal value of 0.05 GBP per share.
• · The reporting persons certify the holdings were not acquired and are not held for the purpose or effect of changing or influencing control of the issuer.

13-10-2026

KED Icon Holdings, LLC (affiliated with Koch, Inc.) amended its Schedule 13D on Getty Images Holdings, Inc. (GETY), disclosing beneficial ownership of 115,259,246 Class A shares, or 27.4% of the 421,018,476 Public Shares outstanding as of August 6, 2026. On October 12, 2026, the Issuer and its subsidiaries entered into a restructuring support agreement for a prepackaged chapter 11 recapitalization, under which KED Parties would provide up to $143 million of DIP financing, a roughly $433 million equity commitment (capped at $158.2 million in cash from KED Parties), and existing public equity and warrants would be cancelled with no distribution. The filing is materially negative for public shareholders while the RSA is a positive step for creditor recovery and the restructuring path.

• · Existing Class A public shares and public warrants will be cancelled with no distribution to holders
• · Holders of claims subject to section 510(b) subordination, including those tied to public warrant litigation, receive nothing
• · General unsecured claims are unimpaired and paid in full in cash
• · Majority shareholders will own 100% of reorganized company upon emergence, subject to management incentive plan dilution and possible New Preferred Interests issued to KED Parties
• · RSA is restrictive: KED Parties and participating Getty Family Stockholders cannot transfer reported securities except per the RSA
• · RSA terminates automatically on the Restructuring Effective Date and may be terminated earlier by Company Parties or requisite Consenting Stakeholders

13-10-2026

Director and Chairman-level insider Kenneth R. Lehman filed an amended Schedule 13D reporting that he acquired 749,535 shares of BayFirst Financial Corp. (BAFN) as the backstop purchaser in the Company's recent rights offering, closing on October 8, 2026. His total beneficial ownership is now 12,249,535 shares, or 39.42% of outstanding common stock, held with sole voting and investment power. The filing states he acquired the shares as a prudent investment and reserves the right to buy more, sell, or engage management and the board on strategy, including via gross-up rights from the April 28, 2026 Securities Purchase Agreement.

• · Lehman's shares were purchased with personal and Roth IRA funds, and he states they reflect a prudent investment rather than a control or activist intent
• · Lehman holds gross-up rights to acquire equity or equity-linked securities the Company issues (subject to exceptions) to maintain his proportionate ownership
• · Filing reserves the right to acquire additional shares, dispose of holdings, or engage management and the board on strategy, governance, and capital structure
• · Lehman is a United States citizen with no criminal or securities-law civil proceedings reported in the last five years
• · Previous filing reference: the Securities Purchase Agreement is incorporated from Exhibit 10.1 to the Company's Form 8-K filed April 30, 2026

13-10-2026

Streeterville Capital LLC, together with its manager Streeterville Management LLC and sole member John M. Fife, reported beneficial ownership of 15,742,464 Class A Ordinary Shares of Solowin Holdings, Ltd. (AXG), equal to 9.99% of the 157,582,228 shares outstanding as of March 31, 2026. The stake is held under a February 9, 2026 Securities Purchase Agreement and related Pre-Paid Purchases, and the reported figure is capped at 9.99% by contract rather than reflecting an unrestricted holding. The filing is a Schedule 13G under Rule 13d-1(c) and includes a certification that the shares were not acquired to influence control of the issuer.

• · Filing type is Schedule 13G (LIVE) with an event date of October 13, 2026, filed under Rule 13d-1(c), a passive-investor designation
• · Streeterville's current contractual ownership cap is 9.99%; the filing notes Line 11 displays only one decimal place
• · All 15,742,464 shares are reported as shared voting and dispositive power, with zero sole voting or dispositive power
• · Reporting persons are Utah LLCs and a U.S. citizen; the issuer is a Hong Kong-based company with a Class A Ordinary Shares listing (CUSIP G82759104)

13-10-2026

Doug Fallon, together with Crazy Roll, Inc. and DR ZAP Holdings, LLC, filed an amended Schedule 13D reporting that their aggregate beneficial ownership of Bragg Gaming Group Inc. common shares has fallen to 1,474,943 shares, or 4.9%, below the 5% reporting threshold. The decline was driven by the Issuer's issuance of 4,500,000 common shares on July 22, 2026 in connection with its acquisition of Drayton International Group, which diluted the reporting persons' percentage holdings despite no open-market selling being reported.

• · Reporting persons' ownership fell below 5% due to dilution from the Issuer's 4,500,000-share issuance, not from disposition by the reporting persons
• · Crazy Roll, Inc. (Delaware) holds 1,393,179 shares with shared voting and dispositive authority; DR ZAP Holdings, LLC (Nevada) holds 50,000 shares
• · Filing reports no contracts, arrangements, or purposes requiring disclosure beyond the threshold-crossing event; no criminal or securities-law civil proceedings in the past five years are disclosed for the Reporting Persons
• · Amendment is signed October 12, 2026 and filed October 13, 2026, roughly 12 weeks after the triggering share issuance

13-10-2026

CEO, Interim CFO, Director and Chairman Huan Liu filed Amendment to Schedule 13D reporting that he bought 100,000 Class B common shares directly from Cheetah Net Supply Chain Service Inc. at $3.30 per share ($330,000 aggregate, personal funds) in a private placement that closed October 9, 2026. Including his prior 1,340 direct Class B shares and 18 shares held via Fairview Eastern International Holdings Limited (his wholly owned BVI entity), he beneficially owns 101,358 Class A shares (as-converted), approximately 7.1% of Class A common stock. The filing also notes the 1-for-150 reverse stock split of September 2026 and the prior 1-for-200 split of April 2026.

• · Purchase was made at $3.30 per share under a Securities Purchase Agreement dated October 7, 2026, with the transaction closing October 9, 2026
• · Reporting Person's stated purpose is investment; the filing states no plans under Items 4(a) through 4(j) beyond those described
• · The Reporting Person is a citizen of the People's Republic of China; Fairview is a British Virgin Islands company
• · Percentage is calculated on 1,332,087 Class A shares plus as-converted Class B shares, per Rule 13d-3(d)(1)
• · Reporting Person reports no criminal convictions or securities-law civil judgments in the past five years

13-10-2026

DOMA Perpetual Capital Management and affiliated reporting persons (including Pedro Escudero and The John Templeton Foundation) filed Amendment No. 4 to their Schedule 13D on Pacira BioSciences (PCRX), disclosing that they ceased to beneficially own more than 5% of the company's common stock as of October 8, 2026, following open-market sales of roughly 2.94 million shares at $36.29 per share. The filing shows zero beneficial ownership at the time of reporting, so the disposition represents a full exit from the position.

• · Aggregate shares sold on October 8, 2026 across the three primary sellers total approximately 2,936,784 shares at $36.29 each, implying roughly $106.6 million in gross proceeds before commissions
• · Prior Schedule 13D amendments were filed August 8, 2025, November 10, 2025, January 2, 2026, and March 12, 2026, indicating a multi-month disposition history
• · Amendment corrects Item 2 disclosures and confirms no criminal or securities-law civil proceedings against the Reporting Persons in the past five years
• · Filing is signed October 13, 2026, and includes a joint filing agreement (Exhibit 99.1) and transaction annex (Exhibit 99.2)

13-10-2026

Michael Sinensky and Aeromaris MAS LLC filed a Schedule 13D reporting beneficial ownership of 19,323,824 shares of Common Stock (16,323,718 held directly via Aeromaris plus 3,000,106 issuable on option exercise), representing approximately 11.6% of outstanding shares, following the October 1, 2026 closing of the merger of Aureus Merger Sub into Autonomous Power Corporation (d/b/a Powerus), after which the Issuer was renamed Powerus Corporation (Nasdaq: PUSA). Aeromaris also holds 2,500,000 Series A Preferred shares (20 votes per share), which the filing estimates give the reporting persons approximately 18.9% of total voting power; the Common Stock percentage excludes this preferred voting power.

• · Aeromaris acquired 2,500,000 Series A Preferred shares from The Steven Scopellite 2021 Irrevocable Trust in exchange for 100,000 Common Shares; two other purchasers each acquired 7,500,000 Series A Preferred shares in the same transaction
• · Merger Agreement dated March 8, 2026, amended July 17, 2026; Merger Sub merged into Powerus with Powerus surviving as a wholly owned subsidiary
• · Lock-up on Lock-Up Shares releases in three tranches of 33.33% each at closing, 90 days, and 180 days after closing
• · Reporting persons state no funds were borrowed to acquire the securities and that holdings are for investment purposes; they may buy or sell additional shares in the future
• · The Exchange Agreement exhibit is dated May 27, 2026 and amends and restates a March 8, 2026 agreement, and the filing text contains a duplicated paragraph on criminal/civil proceedings disclosures

13-10-2026

TIAA (Teachers Insurance and Annuity Association of America), through its wholly owned subsidiary TIAA Global Public Investments, LLC - Series CAT, reported beneficial ownership of 5,000,000 common shares of beneficial interest in Churchill Direct Lending Fund, representing 100.0% of the class as of October 5, 2026. The filing is a Schedule 13G under Rule 13d-1(b), made by an institutional investor that certifies the shares were acquired in the ordinary course of business and not for the purpose of influencing control. The filing contains no financial performance metrics, so there is no period-over-period comparison to report.

• · Filing is a Schedule 13G (Live) under Rule 13d-1(b), indicating an institutional investor filing rather than a passive investor under 13d-1(c)
• · Reporting person is TIAA, with the beneficial ownership held through a wholly owned subsidiary, TIAA Global Public Investments, LLC - Series CAT
• · Reported holdings are as of October 5, 2026, and the filing was signed and dated October 13, 2026
• · Issuer's fiscal year end is December 31; issuer is a New York-incorporated entity headquartered at 375 Park Avenue, New York

13-10-2026

Choo Chee Kong, Chairman and Director of CytoMed Therapeutics Ltd (GDTC), filed an amended Schedule 13D reporting beneficial ownership of 2,974,746 Ordinary Shares, or 24.92% of the 11,934,908 shares outstanding. Between October 5 and October 8, 2026, he bought 62,000 shares on the Nasdaq Capital Market for an aggregate price of approximately $60,554.03, at weighted average prices between $0.9132 and $0.9899 per share. Most of the reported stake is held indirectly through Glorious Finance Limited and EP Capital Inc., and the filing notes a possible group relationship with other Glorious Finance shareholders.

• · Reporting person may be deemed part of a Section 13(d)(3) group with other Glorious Finance Limited shareholders, though no formal voting or investment agreement exists
• · Shares issued to Glorious Finance and EP Capital were described as issued in exchange for capital contributions, while 705,324 directly held shares were acquired with personal funds
• · Purchases were stated to comply with the Issuer's insider trading policy and Rule 10b-5
• · Reporting person undertook to provide per-price purchase detail to the Issuer, shareholders, or the SEC on request

13-10-2026

Sphera Funds Management Ltd. and its affiliated entities (Sphera Global Healthcare GP Ltd. and Sphera Global Healthcare Management LP) filed an amended Schedule 13G reporting beneficial ownership of 2,663,296 shares of Tenax Therapeutics, Inc. common stock, representing 7.09% of the class as of September 30, 2026. The reported position includes 127,600 shares underlying call options exercisable within 60 days, and the filing is a passive Rule 13d-1(c) disclosure with no stated intent to influence control.

• · Position is held under Rule 13d-1(c) and certified as not acquired or held for the purpose of or with the effect of changing or influencing control of the issuer.
• · Sphera Funds Management Ltd. owns 90% of Sphera Global Healthcare GP Ltd., which manages the Management Company.
• · The filing reports the group may be deemed a Section 13(d) group, but the reporting persons disclaim the existence of any group.
• · The filing is an amendment to a prior Schedule 13G (joint filing agreement referenced as filed August 27, 2026), and the document's stated filing date is October 13, 2026 while signatures are dated October 8, 2026.

13-10-2026

Inflection Point Fund I, LP, together with its general partner Inflection Point GP I LLC and investment manager Inflection Point Asset Management LLC, filed a Schedule 13G reporting beneficial ownership of 10,473,478 shares of Common Stock of Merlin, Inc. (formerly Inflection Point Acquisition Corp. IV, ticker BACQU), equal to 9.9% of outstanding shares, as of 09/16/2026. The position is largely held via convertible preferred stock and warrants, with a 9.9% beneficial ownership blocker limiting the reported stake. The filing is a passive-investor disclosure under Rule 13d-1(c) and includes a certification that the shares are not held to influence control of the issuer.

• · Filing is made under Rule 13d-1(c), indicating a passive investor certification that the shares were not acquired to change or influence control of the issuer
• · Investment committee of three members governs voting and dispositive power; the 'rule of three' is invoked so no individual is deemed a beneficial owner
• · Michael Blitzer, who signs for all filers, is also a director of the Issuer, a relevant governance connection
• · Issuer changed its name from Bleichroeder Acquisition Corp. I (2024) to Inflection Point Acquisition Corp. IV (2025) and now Merlin, Inc.

13-10-2026

Bambino 255. V V UG (haftungsbeschrankt) filed an amended Schedule 13G/A reporting that it has fully exited its position in Sono Group N.V. (SSM). The filer previously held 177,417 ordinary shares per the Schedule 13G filed 07/08/2026, and sold them in a series of transactions between 08/10/2026 and 10/01/2026, the largest being 109,652 shares on 09/18/2026. The filing reports zero beneficial ownership (0.00%) as of the reporting date, and the reporting person states it is no longer subject to the 13G certification because it holds no shares.

• · The sales were executed in six tranches over roughly seven weeks, with the position fully liquidated by 10/01/2026
• · The filing is made under Rule 13d-1(c) and the reporting person is an exempt investor filing as a passive holder
• · The reporting person's 13G certification states the shares were not held for the purpose of influencing control of the issuer

13-10-2026

Royce & Associates LP filed an amended Schedule 13G (Rule 13d-1(d)) reporting beneficial ownership of 586,822 shares of Aviat Networks common stock as of September 30, 2026, representing 4.56% of the outstanding class. The filer reports sole voting and dispositive power over all reported shares and certifies the holdings were acquired in the ordinary course of business without a purpose of changing or influencing control. The filing is a routine passive ownership disclosure with no transaction price, acquisition, or control-related action described.

• · Filer holds 0 shares with shared voting or dispositive power; all 586,822 shares are under sole authority
• · Royce disclaims any pecuniary interest and any group relationship with Franklin Resources affiliates or the Johnson principal shareholders
• · Filing made under Rule 13d-1(d), consistent with a passive investor status rather than a 13D control filing

13-10-2026

Royce & Associates LP, an investment adviser and indirect majority-owned subsidiary of Franklin Resources, filed a Schedule 13G/A reporting beneficial ownership of 1,089,226 shares of Barrett Business Services, Inc. (BBSI) common stock as of September 30, 2026, representing 4.49% of the outstanding class. The filing is a passive, ordinary-course disclosure under Rule 13d-1(d), with sole voting and dispositive power over all reported shares and a certification that the securities were not acquired to influence control of the issuer.

• · Holdings are reported as sole investment discretion and sole voting authority on behalf of Royce's investment management clients (registered investment companies and managed accounts)
• · Filing made under Rule 13d-1(d), indicating a passive investor status rather than a 13D control-intent filing
• · Royce disclaims beneficial ownership attribution to Franklin Resources' principal shareholders and disclaims any group relationship with affiliates

13-10-2026

Hui Li filed an amended Schedule 13G (Rule 13d-1(c)) reporting beneficial ownership of 11,000,000 Class A ordinary shares of uCloudlink Group Inc. (held as 1,100,000 ADSs), representing 4.26% of the outstanding Class A shares. The filing is a passive-investor disclosure with an event date of 09/30/2026 and certifies the holding was not acquired to influence control of the issuer. No change in the reported stake amount is stated in the filing text provided.

• · Filing made under Rule 13d-1(c), indicating passive investor status with no control intent certification
• · Event date of 09/30/2026; filing date October 13, 2026
• · Ownership is reported as sole voting and dispositive power over 11,000,000 shares, with no shared power reported
• · Issuer CUSIP is 90354D104; reporting person is an individual based in Shenzhen, PRC

13-10-2026

Wasatch Advisors LP filed an amended Schedule 13G reporting that, as of 09/23/2026, it no longer beneficially owns any shares of Smith Douglas Homes Corp. (SDHC) Class A common stock, reporting 0 shares and 0.0% ownership. The filing is a routine exit disclosure under Rule 13d-1(b) for an investment adviser and does not indicate any change in control or strategic intent.

• · Filing type is Schedule 13G/A (LIVE), filed 10/13/2026 with signature dated 10/12/2026 under Rule 13d-1(b), indicating an institutional investment adviser filer
• · Wasatch Advisors LP is a Delaware entity based at 505 Wakara Way, Salt Lake City, UT, and certified its holdings were acquired and held in the ordinary course of business without control intent
• · SDHC is an operative homebuilder (SIC 1531), headquartered in Woodstock, GA, with CUSIP 83207R107

13-10-2026

Reinhart Partners, LLC filed an amended Schedule 13G/A reporting its beneficial ownership in AdaptHealth Corp. (AHCO) as of the 03/31/2025 event date, with the filing dated October 13, 2026. The filing reports 0 shares beneficially owned, 0.00% of the class, and 0 sole or shared voting and dispositive power, indicating the filer no longer holds a reportable stake. The filing is a routine exit-style amendment under Rule 13d-1(b) for an investment adviser and includes no transaction value or new strategic information.

• · Filing is a Schedule 13G/A (amendment) for Common Stock, CUSIP 00653Q102, with a 03/31/2025 event date
• · Filer certifies holdings were acquired in the ordinary course and not for the purpose of influencing control of the issuer

13-10-2026

Reinhart Partners, LLC filed an amended Schedule 13G (Amendment No. 1, reporting date-of-event 06/30/2025) on October 13, 2026 disclosing beneficial ownership of 8,569,262 shares of Hillman Solutions Corp. (HLMN) common stock, representing 4.4% of the class. The filing reports sole voting power over 7,855,824 shares and shared dispositive power over 8,569,262 shares, and is filed by Reinhart as an investment adviser under Rule 13d-1(b). The filing is a routine passive-holder disclosure with no stated intent to influence control.

• · Filing is an amendment (SCHEDULE 13G/A) with date-of-event 06/30/2025, indicating the reported holdings are as of that date rather than the filing date
• · Reinhart certifies the shares were acquired and are held in the ordinary course of business without the purpose or effect of changing or influencing control of the issuer
• · Filer is classified under Rule 13d-1(b) as an investment adviser (IA)
• · Issuer CIK 0001822492; SEC file number 005-91767; issuer formerly known as Landcadia Holdings III, Inc.

13-10-2026

Empery Asset Management, LP and its managing principal Ryan M. Lane report beneficial ownership of 221,660 shares of Clene Inc. (CLNNW) common stock, representing 1.56% of outstanding shares, as of September 30, 2026. The shares are held by Empery-managed funds, and the filing is an amendment (SC 13G/A) filed under Rule 13d-1(b) by an investment adviser certifying the position was acquired in the ordinary course of business without intent to influence control. The filing reports no sole voting or dispositive power beyond shared power over the 221,660 shares.

• · Filing references a prior Schedule 13G (accession 0000919574-26-004749) that this amendment supersedes.
• · Reporting Persons disclaim beneficial ownership of the shares held by the Empery Funds beyond their pecuniary interest.
• · Filing is categorized under Rule 13d-1(b), used by qualified institutional investors such as registered investment advisers, rather than a passive 13d-1(c) or active 13D filing.

13-10-2026

Loo See Yuen, CEO and director of Bradbury Capital Inc. (formerly TETE Technologies Inc., ticker RADB in the request; the filing references BBCI/BBCIW on Nasdaq), filed a Schedule 13D reporting beneficial ownership of 14,725,000 Ordinary Shares, or approximately 52.66% of the 27,960,384 shares outstanding as of October 6, 2026. The stake follows the closing on October 6, 2026 of a business combination with Bradbury Capital Holdings Inc. under which 110,000,000 new shares valued at $10.00 each were issued as aggregate consideration of $1,100,000,000, of which $235,000,000 was paid at closing and $865,000,000 is subject to earn-out provisions. The filing discloses a six-month lock-up on the reporting person's shares, with exceptions noted.

• · Lock-up restricts disposition of Lock-Up Shares for six months after the October 6, 2026 closing, but is released entirely upon a Change of Control
• · Filing references a Form-4 Registration Statement filed March 9, 2026 and declared effective March 20, 2026, which is an inconsistent form reference
• · Filing states the Closing Payment Shares were 14,100,00 shares for Bradbury Private Investment XVIII, a typographical discrepancy versus 14,100,000 elsewhere
• · Filing states the Merger Agreement is dated August 2, 2023, while the Company's name change date is July 21, 2023

13-10-2026

JPMorgan Chase & Co. filed an amended Schedule 13G (SC 13G/A) disclosing beneficial ownership in LB Pharmaceuticals Inc (LBRX) as of September 30, 2026. The filing reports aggregate beneficial ownership of 1,401,790 shares, equal to 4.3% of the class, with sole voting power over 1,334,100 shares (7.0%) and shared dispositive power over 1,401,783 shares (7.0%). The filing is made under Rule 13d-1(b) by a holding company on a passive basis, with certification that the shares are not held to influence control of the issuer.

• · Filing is an amendment (SC 13G/A) filed under Rule 13d-1(b), indicating a passive institutional holder rather than an activist or control-seeking investor
• · Reported percent-of-class figures (4.3% aggregate vs. 7.0% voting/dispositive) are internally inconsistent in the filing and may reflect a data or reporting error that warrants verification against the primary EDGAR document
• · Ownership is held through several JPMorgan subsidiaries, including JPMorgan Asset Management entities and J.P. Morgan Investment Management Inc.
• · Certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control of the issuer

13-10-2026

JPMorgan Chase & Co. filed a Schedule 13G/A reporting beneficial ownership of 1,820,302 shares of Kulicke & Soffa Industries Inc (KLIC) common stock as of September 30, 2026, representing 3.4% of the class. The filing is a passive holding disclosure made under Rule 13d-1(b) with a certification that the shares are held in the ordinary course of business and not to influence control. No change in control or transaction is described.

• · Reporting person is classified as a parent holding company (HC) with aggregated holdings across multiple JPMorgan subsidiaries
• · Ownership is reported as of September 30, 2026 and the filing was made October 13, 2026
• · Sole voting power covers 1,689,528 shares, with only 1,556 shares under shared voting power

13-10-2026

JPMorgan Chase & Co. filed a Schedule 13G reporting beneficial ownership of 3,678,005 shares of HubSpot, Inc. common stock, representing 7.3% of the class as of September 30, 2026. The filing is made under Rule 13d-1(b), a passive institutional holder certification, and reflects shared voting and dispositive power over the bulk of the position. No activist intent or control purpose is indicated.

• · Filed under Rule 13d-1(b), indicating a passive institutional holder certification rather than a 13D activist filing
• · Ownership is held through multiple JPMorgan subsidiaries, including J.P. Morgan Securities LLC and J.P. Morgan Investment Management Inc.
• · Filing status is LIVE, with the reporting date as of 09/30/2026 and signature dated 10/13/2026
• · Certification states the shares were acquired and are held in the ordinary course of business, not to change or influence control of the issuer

13-10-2026

JPMorgan Chase & Co. filed an amended Schedule 13G reporting beneficial ownership of 20,839,207 shares of Entergy Corporation common stock as of September 30, 2026, representing 4.4% of the class. The filing shows sole voting power over 19,284,824 shares and shared voting power over 107,588 shares, with sole dispositive power over 20,732,108 shares and shared dispositive power over 102,089 shares. The filing is a passive, ordinary-course disclosure under Rule 13d-1(b) and does not indicate any change in control intent.

• · Filing is a SCHEDULE 13G/A filed under Rule 13d-1(b), indicating a institutional/passive holder certification rather than an activist 13D filing
• · Holdings are reported across multiple JPMorgan subsidiaries, including banking, broker-dealer, trust, and asset management entities
• · Filer certifies the shares were acquired and are held in the ordinary course of business without intent to change or influence control of Entergy

13-10-2026

Streeterville Capital LLC, Streeterville Management, LLC, and John M. Fife filed a Schedule 13G/A amendment reporting that they now beneficially own 0 shares (0.0% of Class A common stock) of Alpha Modus Holdings, Inc. (AMODW), as of October 13, 2026. The filing reflects a full exit from prior holdings, reported under Rule 13d-1(c), with a certification that the securities were not acquired or held to influence control of the issuer.

• · Filing is a Schedule 13G/A (LIVE) with an event date of 10/13/2026, signed by John Fife as President of both Streeterville entities.
• · Reporting persons are filing jointly; Streeterville Capital LLC is the direct holder while the other reporting persons are indirect beneficial owners, but all report zero shares.
• · Issuer's former names were Insight Acquisition Corp. (name change 2021) and Alpha Modus Holdings, Inc. (name change 2024-12-19).
• · Filing was made under Rule 13d-1(c), a passive-investor designation, rather than as an activist or control-seeking filer.

13-10-2026

Drew Holdings Ltd., wholly owned by Borr Drilling director Tor Olav Troim, filed a Schedule 13D reporting beneficial ownership of 37,367,808 common shares of Borr Drilling Ltd, or 12.2% of 307,391,018 shares outstanding, up from its prior Schedule 13G/A filed August 5, 2026. The filing reports nine open-market purchases between August 13 and October 9, 2026 at prices ranging from $4.02 to $4.74 per share, alongside a 54,545-share director compensation award vesting September 30, 2026. The reporting persons state the holdings are for investment purposes and that they may acquire, sell, or distribute shares, and Troim may participate in Issuer governance discussions in his director capacity.

• · Drew Holdings' purchases over the past 60 days total roughly 9.6 million shares, with the most recent purchases at elevated prices near $4.74 on October 9, 2026.
• · The filing was made under 15 U.S.C. 78m(d)(6)(B) after the holder acquired more than 2% of shares in the preceding twelve months, shifting reporting from Schedule 13G to 13D.
• · Troim is a director with potential participation in governance matters, and the reporting persons reserve the right to change purpose, sell, hedge, or distribute shares.

13-10-2026

Ryan Cohen filed Amendment No. 21 to his Schedule 13D on GameStop Corp. (GME) disclosing open-market purchases on October 13, 2026 of 67,130 Shares at $26.7500 and 777,000 Shares at $27.0000. Following these purchases, Cohen beneficially owns 46,227,436 Shares, including 3,734,784 Shares underlying warrants, representing approximately 9.1% of outstanding Class A Common Stock. The filing reports no other transactions since Amendment No. 20.

• · Cohen's October 13, 2026 purchases were made entirely in the open market.
• · Ownership percentage is calculated against 504,500,990 Shares outstanding plus warrant shares that may be exercised by Cohen.
• · Cohen's 3,734,784 warrants were received for no consideration via a warrant dividend distribution to all Issuer stockholders.

13-10-2026

HBM Healthcare Investments (Cayman) Ltd. filed a Schedule 13G on October 13, 2026 reporting beneficial ownership of 22,505,819 Common Shares of Vicore Pharma Holding AB, approximately 8% of outstanding shares as of the filing date (down from 22,687,752 shares, or about 8.1%, as of June 30, 2026). The filing reports sole voting and dispositive power and is made under Rule 13d-1(d), which applies to passive holders who acquired shares before the issuer's registration under Section 12. The reported position declined slightly over the period, with no change in the reporting person's sole voting or investment authority.

• · Each American Depositary Share (CUSIP 92581R104) represents ten Common Shares; the reported position is stated in Common Shares, not ADSs
• · Voting and investment power is exercised collectively by the reporting person's Board, with no individual board member holding individual power over the shares
• · Filed under Rule 13d-1(d) as a passive holder; the filing is a LIVE submission with Cayman Islands as the reporting person's jurisdiction

13-10-2026

Vivo Opportunity, LLC and its affiliated funds filed a Schedule 13G disclosing an aggregate beneficial ownership of 2,472,701 shares of ArriVent BioPharma, Inc. (AVBP) common stock, representing 5.0% of outstanding shares, as of an event date of October 6, 2026. The filing is made under Rule 13d-1(c) as a passive investor, with the reporting persons certifying that the shares were not acquired to influence control of the issuer. Percentages are based on 49,307,729 shares outstanding as of August 10, 2026, per the issuer's Form 10-Q.

• · Filing is a Schedule 13G under Rule 13d-1(c), indicating a passive investor certification rather than an active control intent
• · Event date of beneficial ownership is October 6, 2026; filing date is October 13, 2026
• · Filing is a LIVE (initial) submission covering Common Stock, $0.0001 par value, CUSIP 04272N102
• · Vivo Opportunity, LLC is general partner of three Delaware funds and deemed beneficial owner of their combined holdings; Vivo Opportunity Cayman, LLC is general partner of the Cayman fund

13-10-2026

PointState Capital LP and its affiliated reporting persons, led by Zachary J. Schreiber, filed a Schedule 13G disclosing beneficial ownership of 9,352,256 shares of Knight-Swift Transportation Holdings Inc. (KNX) common stock, representing approximately 5.7% of the outstanding class. The position is held through SteelMill Master Fund LP, with ownership reported as of October 8, 2026, and the filing certifies the shares were not acquired for the purpose of influencing control of the issuer.

• · Filing is a Schedule 13G filed under Rule 13d-1(c), indicating a passive investor certification rather than an activist 13D filing
• · Reporting persons state the shares were not acquired and are not held to change or influence control of the issuer
• · Ownership reported as of 10/08/2026; filing dated October 13, 2026, with status marked LIVE
• · Joint filing agreement (Exhibit 99.1) filed under Rule 13d-1(k)(1); reporting persons disclaim group status
• · Reported voting power is zero sole and 9,352,256 shared, with dispositive power structured the same way

13-10-2026

CVI Investments, Inc., with Heights Capital Management, Inc. as its investment manager, filed a Schedule 13G reporting beneficial ownership of 800,000 Class A Ordinary Shares of Pine Tree Acquisition Corp. (PAXG), representing 7.6% of the class, as of October 6, 2026. The filing is a passive ownership disclosure under Rule 13d-1(c), with the reporting persons certifying no intent to influence control of the issuer.

• · Shares are held as part of units issued in the Company's IPO under Prospectus Registration No. 333-292289, filed October 6, 2026.
• · Heights Capital Management, Inc. may be deemed beneficial owner of the shares through its role as investment manager and disclaims beneficial ownership except for pecuniary interest.
• · Filing was signed October 13, 2026, under a Limited Power of Attorney and a Joint Filing Agreement under Rule 13d-1(k).

13-10-2026

S.H.N. Financial Investments Ltd. filed a Schedule 13G reporting beneficial ownership of 614,284 Class A Ordinary Shares of DarkIris Inc. (DKI), representing 9.99% of the class, as of October 8, 2026. The position is held under Rule 13d-1(c), a passive investor filing, and the holder certifies it was not acquired to influence control of the issuer. The stake is capped at 9.99% due to a beneficial ownership limitation, with additional pre-funded warrants and warrants excluded from the reported figure.

• · Filing is a passive Rule 13d-1(c) Schedule 13G, with the reporting person certifying no intent to change or influence control of the issuer
• · Reporting person is Israel-based (Herzliya), while the subject company's business address is in Hong Kong
• · Ownership percentage is computed against 5,834,367 shares outstanding following an October 2026 offering
• · Filer's CEO Nir Shamir may be deemed to beneficially own the securities but disclaims beneficial ownership for other purposes
• · Filing is categorized as a LIVE filing dated October 13, 2026, with the event date listed as October 8, 2026

13-10-2026

CVI Investments, Inc., with its investment manager Heights Capital Management, Inc., filed a Schedule 13G reporting beneficial ownership of 1,588,266 shares of Sunshine Biopharma Inc. common stock, representing 9.9% of the class as of October 8, 2026. The position consists of 909,090 shares plus warrants, which are contractually limited from exercise to the extent they would push beneficial ownership above 9.99%. The filing is a passive-investor disclosure under Rule 13d-1(c) and includes a certification that the shares are not held to influence control of the issuer.

• · Event date of beneficial ownership is October 8, 2026; the Schedule 13G was filed October 13, 2026 under Rule 13d-1(c) as a passive investor.
• · Reporting persons disclaim beneficial ownership except for pecuniary interest, and Heights Capital Management acts as investment manager with shared voting and dispositive power over the position.
• · Filing includes a Limited Power of Attorney dated July 16, 2015 and a Joint Filing Agreement, both executed by Sarah Travis and William Walmsley.

13-10-2026

Jane Street Group, LLC and its subsidiaries Jane Street Capital, LLC and Jane Street Global Trading, LLC filed a Schedule 13G disclosing beneficial ownership of 35,819 shares of common stock of Aethlon Medical Inc (AEMD), representing 5.0% of the class, as of 10/06/2026, under Rule 13d-1(c) as passive investors. The filing states the securities were not acquired and are not held to change or influence control of the issuer.

• · Filing is a Schedule 13G (LIVE) under Rule 13d-1(c), a passive-investor designation rather than an activist 13D filing.
• · Holdings are split: Jane Street Global Trading, LLC holds 28,974 shares (4.1%) and Jane Street Capital, LLC holds 6,845 shares (1.0%); the parent reports 0 shares with sole voting power and 0 with sole dispositive power, with the holdings reported as shared.
• · Subject company is Aethlon Medical Inc, San Diego, CA (CIK 0000882291), fiscal year end March 31; the filing date is October 13, 2026.

13-10-2026

Morgan Stanley and its subsidiary Morgan Stanley Smith Barney LLC filed an amended Schedule 13G reporting beneficial ownership of 245,955 shares of the 4.75% Series B Cumulative Preferred Shares (CUSIP 76882G404) of RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (OPP-PC), representing 10.2% of the class as of August 31, 2026. The filing is a passive-investor disclosure made under Rule 13d-1(b) and reports sole voting and dispositive power over the reported shares with no shared power.

• · Filing is an amendment (SC 13G/A) filed October 13, 2026 under Rule 13d-1(b), indicating a qualified institutional filer (broker-dealer/investment adviser/holding company) rather than an activist filer.
• · Morgan Stanley Smith Barney LLC is classified as a broker-dealer (BD) and investment adviser (IA); Morgan Stanley is classified as a holding company (HC), and the stake is held through the subsidiary.
• · Filing states the certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• · Filing references Morgan Stanley reporting units under SEC Release No. 34-39538; ownership disaggregated from these units is not reflected.
• · Joint Filing Agreement (Exhibit 99.1) and Item 7 disclosure (Exhibit 99.2) confirm that Morgan Stanley reports the securities as parent holding company for its wholly-owned subsidiary Morgan Stanley Smith Barney LLC.

13-10-2026

Portolan Capital Management, LLC and its Manager George McCabe report beneficial ownership of 2,405,785 shares of Lantronix Inc (LTRX) common stock, representing 5.15% of the class, on a Schedule 13G filed under Rule 13d-1(c) with an event date of October 6, 2026. The shares are held directly by Portolan as investment manager for various clients, with McCabe reporting indirect beneficial ownership, and the filers certify the holdings are passive and not for the purpose of influencing control of the issuer.

• · Filing is a passive Rule 13d-1(c) disclosure: the filers certify the shares were not acquired for the purpose of changing or influencing control of the issuer
• · Each reporting person holds sole voting and dispositive power over the 2,405,785 shares, with no shared power and no shares held in sole or shared capacity beyond this
• · Portolan is a registered investment adviser (Boston, MA) and reports the holdings on behalf of its advisory clients

13-10-2026

Millennium Management LLC and affiliated entities (Integrated Core Strategies (US) LLC, Millennium Group Management LLC, and Israel A. Englander) filed a Schedule 13G/A reporting passive beneficial ownership in WW International, Inc. common stock as of September 30, 2026. Aggregate beneficial ownership is 39,219 shares (approximately 0.4% of the class), with Integrated Core Strategies holding 30,058 shares (approximately 0.3%). The filing is made under Rule 13d-1(c) and includes a certification that the securities are not held to influence control of the issuer.

• · Ownership is reported under Rule 13d-1(c), a passive-investor designation, and the filer certifies the shares are not held for the purpose of changing or influencing control of WW International.
• · Shares are held by entities under voting control and investment discretion of Millennium Management LLC and/or affiliated investment managers; the filing states this should not be construed as an admission of beneficial ownership by the reporting persons.
• · Filing is a joint filing under Exhibit I Joint Filing Agreement dated October 12, 2026.
• · Percentages are small (0.3% and 0.4%) relative to the class, and the filing does not indicate a change from prior reported holdings.

13-10-2026

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G/A reporting beneficial ownership of 29,686 shares of Ameresco, Inc. (AMRC) Class A Common Stock as of September 30, 2026, representing approximately 0.1% of the class. The filing is a passive Rule 13d-1(c) disclosure, with the filers certifying the shares were not acquired to influence control of the issuer. No change in control intent or transaction is reported.

• · Event date (as of) is September 30, 2026; filing made October 13, 2026 under Rule 13d-1(c), indicating a passive investor filing.
• · Shares are held by entities under voting control and investment discretion of Millennium Management LLC and/or affiliated investment managers; the filing disclaims beneficial ownership as an admission.
• · Ownership is reported as a 13G/A amendment (LIVE status), updating a prior beneficial ownership position for Ameresco's Class A Common Stock (CUSIP 02361E108).

13-10-2026

Vivek Ramaswamy and Virtuous Industries LLC filed Amendment No. 3 to their Schedule 13D on Strive, Inc. (ASST) to update their percentage of class ownership, not to report a new transaction. The filing reports Ramaswamy beneficially owns 5,693,897 Class A shares (5.6%) and Virtuous Industries holds 106,245 shares (0.1%), with both figures assuming conversion of Class B Common Stock. The percentage change is attributed to ongoing Class A issuance under the company's at-the-market equity offering program, and the filing states no transactions were effected in the 60 days preceding the filing.

• · Amendment No. 3 supersedes prior amendments filed May 11, 2026 (original), June 1, 2026 (Amendment No. 1), and August 26, 2026 (Amendment No. 2)
• · Ownership percentages are updated solely due to Issuer share issuance, not a change in the Reporting Persons' holdings
• · Reporting Persons effected no Class A transactions during the 60 days preceding the filing, except as otherwise described
• · Ramaswamy and Virtuous Industries hold sole voting and dispositive power over their respective shares

13-10-2026

Sculptor Capital LP and affiliated reporting entities filed a Schedule 13G disclosing beneficial ownership of 928,563 Class A ordinary shares of Helix Acquisition Corp. III (HLXC), representing 5.23% of the outstanding class, as of October 6, 2026. The filing is a passive-investor disclosure under Rule 13d-1(c), with the reporting persons certifying the shares were not acquired to influence control of the issuer.

• · Helix Acquisition Corp. III is a blank-check (SPAC) company; the reporting persons hold its Class A ordinary shares through private funds and discretionary accounts they manage.
• · The filing lists the issuer's business address as c/o Cormorant Asset Management LP, Boston, MA, and the filer's address as 9 West 57th Street, New York, NY, reflecting Sculptor's former OZ Management name history.
• · Sculptor Capital LP and its affiliates are filing as passive investors (Rule 13d-1(c)), and the filing type is an initial/live Schedule 13G rather than a 13D, indicating no intent to influence control.
• · All voting and dispositive power is reported as shared-dispositive (928,563 shares) with zero sole power, and beneficial ownership is disclaimed as to the Accounts' underlying interests per the standard Release 34-39538 language.

13-10-2026

Streeterville Capital LLC, together with its manager Streeterville Management LLC and sole member John M. Fife, reports beneficial ownership of 1,443,587 shares of Professional Diversity Network, Inc. (IPDN) common stock, equal to 9.99% of the 14,450,323 shares outstanding as of August 14, 2026. The position is held under a Pre-Paid Purchase #1 agreement that caps Streeterville's ownership at 9.99%, so the reported stake is constrained by contract rather than reflecting the full economic exposure. The filing is a Schedule 13G/A amendment filed under Rule 13d-1(c) and certifies the securities were not acquired to influence control of the issuer.

• · Streeterville's 9.99% ownership cap is contractual; the form's line 11 displays only one decimal place (9.9%).
• · Reporting persons certify the shares were not acquired or held to change or influence control of the issuer.
• · Filing is a Schedule 13G/A amendment (live filing) dated October 13, 2026, reported under Rule 13d-1(c), a passive investor category.
• · Reporting persons are Utah limited liability companies and John M. Fife is a U.S. citizen; principal business address is Chicago, IL.

13-10-2026

Joseph Michael Lubin and affiliated entities (Consensys Software Inc., Consensys AG, Permanent Highest Power Capital LLC, and Ethereal Ventures Fund II L.P.) filed Amendment No. 2 to their Schedule 13D on October 13, 2026, disclosing that they collectively beneficially own 10,866,132 shares of SharpLink (SBET) common stock, or approximately 4.9%, and have ceased to be 5%+ holders as of October 8, 2026. The change followed CSI's sale of all 5,676,952 shares in a block trade at $8.39 per share on October 8, 2026, to liquidate its position, while the increase in outstanding shares to 217,223,604 (as of August 3, 2026) triggered the exercise of pre-funded warrants held by the reporting persons. Sentiment is neutral: the filing reports a large insider exit alongside a holder-status change driven by estate planning and dilution mechanics.

• · CSI sold all 5,676,952 shares in a block trade at $8.39 per share on October 8, 2026, to liquidate its position
• · Pre-funded warrants held by Lubin, PHPC LLC, and CSI were exercised for nominal consideration after the increase in outstanding shares permitted exercise under beneficial ownership limits
• · Lubin contributed pre-funded warrants for up to 1,200,000 shares to PHPC LLC and then gifted all PHPC LLC interests to a trust, for estate planning purposes
• · Lubin disclaims beneficial ownership of securities held by CSI and CAG
• · Reporting Persons ceased to be 5%+ beneficial owners as of October 8, 2026
• · Reporting Persons have no current plans to change board composition, management, or board size, though future equity awards to Lubin as Chairman are possible
• · Prior Amendment No. 1 was filed April 16, 2026; the original Schedule 13D was filed June 6, 2025

13-10-2026

Glenview Capital Management, LLC and its Chief Investment Officer Larry Robbins filed a Schedule 13G disclosing beneficial ownership of 7,023,338 shares of Surgery Partners, Inc. (SGRY) common stock, equal to approximately 5.4% of the 130,918,260 shares outstanding as of August 3, 2026. The filing is a passive-investor disclosure under Rule 13d-1(c), and the reporting persons certify the shares were not acquired to influence control of the issuer.

• · Event date of the reportable change is October 6, 2026, per the filing; the filing itself is dated October 13, 2026
• · Filing is made under Rule 13d-1(c), indicating a passive investor rather than an activist 13D filer
• · Reporting persons disclaim control intent; joint filing agreement and power of attorney are attached as exhibits